OBJECTIVE: The purpose of this investigation was to examine serum vitamin D status in a population of Punjabi ancestry from Northern India with a high prevalence of type 2 diabetes (T2D) and evaluate the effects of 25(OH)D levels on cardio-metabolic traits. RESEARCH DESIGN AND METHODS: We assessed cardiovascular risk factors and 25(OH)D levels in 1,765 participants (887 T2D cases, 878 normoglycemic controls). RESULTS: 76% of individuals were deficient (<50 nmol/L) in vitamin D. A higher percentage of T2D participants(83%) were vitamin D deficient compared to normoglycemic controls (68%)(p<0.0001).The prevalence of vitamin D deficiency increased progressively with body mass index (BMI) categories (p<0.0001): BMI<23 kg/m2, 65%; BMI 23-27.5 kg/m2, 75%; and BMI>27.5 kg/m2, 81%. T2D participants had significantly decreased serum 25(OH)D levels (β=-0.41, p=2.8 × 10-20). Individuals with low serum 25(OH)D had elevated fasting glucose(β=-0.18, p=0.022), BMI (β=-0.71, p=1.4 × 10-7) and systolic blood pressure (β=-1.68, p=0.006). A positive association of increased 25(OH)D with HOMA-B (β=0.17, p=8.0×10-6), and C-peptide (β=0.09, 0.017) was observed. Non-medicated, normoglycemic, non-hypertensive individuals classified as vitamin D deficient (n=289) exhibited a significant increase in fasting glucose (p=0.02) and BMI (p<0.0001) as well as a significant decrease in C-peptide (p<0.0001) and amylin (p<0.0001) compared to vitamin D sufficient controls (n=150). CONCLUSIONS: Vitamin D deficiency appears to be a significant risk factor for T2D severity and associated cardio-metabolic risk. Early intervention may be considered to improve prevention of T2D related cardiovascular complications.
OBJECTIVE: The purpose of this investigation was to examine serum vitamin D status in a population of Punjabi ancestry from Northern India with a high prevalence of type 2 diabetes (T2D) and evaluate the effects of 25(OH)D levels on cardio-metabolic traits. RESEARCH DESIGN AND METHODS: We assessed cardiovascular risk factors and 25(OH)D levels in 1,765 participants (887 T2D cases, 878 normoglycemic controls). RESULTS: 76% of individuals were deficient (<50 nmol/L) in vitamin D. A higher percentage of T2D participants(83%) were vitamin D deficient compared to normoglycemic controls (68%)(p<0.0001).The prevalence of vitamin Ddeficiency increased progressively with body mass index (BMI) categories (p<0.0001): BMI<23 kg/m2, 65%; BMI 23-27.5 kg/m2, 75%; and BMI>27.5 kg/m2, 81%. T2D participants had significantly decreased serum 25(OH)D levels (β=-0.41, p=2.8 × 10-20). Individuals with low serum 25(OH)D had elevated fasting glucose(β=-0.18, p=0.022), BMI (β=-0.71, p=1.4 × 10-7) and systolic blood pressure (β=-1.68, p=0.006). A positive association of increased 25(OH)D with HOMA-B (β=0.17, p=8.0×10-6), and C-peptide (β=0.09, 0.017) was observed. Non-medicated, normoglycemic, non-hypertensive individuals classified as vitamin D deficient (n=289) exhibited a significant increase in fasting glucose (p=0.02) and BMI (p<0.0001) as well as a significant decrease in C-peptide (p<0.0001) and amylin (p<0.0001) compared to vitamin D sufficient controls (n=150). CONCLUSIONS:Vitamin Ddeficiency appears to be a significant risk factor for T2D severity and associated cardio-metabolic risk. Early intervention may be considered to improve prevention of T2D related cardiovascular complications.
Authors: James L Vacek; Subba Reddy Vanga; Mathew Good; Sue Min Lai; Dhanunjaya Lakkireddy; Patricia A Howard Journal: Am J Cardiol Date: 2011-11-08 Impact factor: 2.778
Authors: R M Anjana; R Pradeepa; M Deepa; M Datta; V Sudha; R Unnikrishnan; A Bhansali; S R Joshi; P P Joshi; C S Yajnik; V K Dhandhania; L M Nath; A K Das; P V Rao; S V Madhu; D K Shukla; T Kaur; M Priya; E Nirmal; S J Parvathi; S Subhashini; R Subashini; M K Ali; V Mohan Journal: Diabetologia Date: 2011-09-30 Impact factor: 10.122
Authors: Francesco Panero; Giulia Novelli; Chiara Zucco; Paolo Fornengo; Massimo Perotto; Olivia Segre; Giorgio Grassi; Paolo Cavallo-Perin; Graziella Bruno Journal: Diabetes Care Date: 2008-11-18 Impact factor: 17.152
Authors: Dharambir K Sanghera; Lyda Ortega; Shizhong Han; Jairup Singh; Sarju K Ralhan; Gurpreet S Wander; Narinder K Mehra; John J Mulvihill; Robert E Ferrell; Swapan K Nath; Mohammed I Kamboh Journal: BMC Med Genet Date: 2008-07-03 Impact factor: 2.103
Authors: Iciar Martín-Timón; Cristina Sevillano-Collantes; Amparo Segura-Galindo; Francisco Javier Del Cañizo-Gómez Journal: World J Diabetes Date: 2014-08-15
Authors: Richa Saxena; Andrew Bjonnes; Jennifer Prescott; Patrick Dib; Praveen Natt; Jacqueline Lane; Megan Lerner; Jackie A Cooper; Yuanqing Ye; Ka Wah Li; Cécilia G Maubaret; Veryan Codd; Daniel Brackett; Lisa Mirabello; Peter Kraft; Colin P Dinney; Donald Stowell; Marvin Peyton; Sarju Ralhan; Gurpreet S Wander; Narinder K Mehra; Klelia D Salpea; Jian Gu; Xifeng Wu; Massimo Mangino; David J Hunter; Immaculata De Vivo; Steve E Humphries; Nilesh J Samani; Tim D Spector; Sharon A Savage; Dharambir K Sanghera Journal: Circ Cardiovasc Genet Date: 2014-05-03
Authors: Eric W Howard; Latonya F Been; Megan Lerner; Daniel Brackett; Stan Lightfoot; Elizabeth C Bullen; Dharambir K Sanghera Journal: BMC Genet Date: 2013-04-23 Impact factor: 2.797
Authors: Cynthia A Bejar; Shiwali Goyal; Shoaib Afzal; Massimo Mangino; Ang Zhou; Peter J van der Most; Yanchun Bao; Vipin Gupta; Melissa C Smart; Gagandeep K Walia; Niek Verweij; Christine Power; Dorairaj Prabhakaran; Jai Rup Singh; Narinder K Mehra; Gurpreet S Wander; Sarju Ralhan; Sanjay Kinra; Meena Kumari; Martin H de Borst; Elina Hyppönen; Tim D Spector; Børge G Nordestgaard; Piers R Blackett; Dharambir K Sanghera Journal: Nutr J Date: 2021-07-27 Impact factor: 3.271